Automated Inhaler Monitoring for Asthma Medication Usage

The goal of this clinical trial is to evaluate the aflo™ digital platform's ability to improve inhaler use technique and asthma control for children, adolescents, and adults with uncontrolled asthma. The main questions the trial aims to answer are: 1. Does the platform improve medication adherence and inhaler technique, as measured by the Inhaler Proficiency Score (IPS)? 2. Does the aflo™ platform improve asthma control, as measured by changes in the Asthma Control Test (ACT) and lung function tests (FEV1, PEF)? Participants will: * Use the aflo™ sensor with their asthma inhaler to receive real-time feedback on technique and medication adherence reminders. * Track asthma symptoms and quality of life through a mobile app. * Complete assessment visits and surveys at the start and end of the 3-month study and 2 interim asthma assessment phone calls.

NCT Number	NCT06825871
Lead Sponsor	Boston Children's Hospital Collaborators: Respiratory Analytics Ltd
Conditions	Asthma
Enrollment	20 participants
Start Date	2025-12-01
Primary Completion	2026-06-26 (estimated)
Study Completion	2026-06-26 (estimated)
Updated on ClinicalTrials.gov	2026-07-29